{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:45:30Z","timestamp":1790196330242,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.01238","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T05:23:36Z","timestamp":1597123416000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":58,"title":["The Inflammasome Signaling Proteins ASC and IL-18 as Biomarkers of Psoriasis"],"prefix":"10.3389","volume":"11","author":[{"given":"Mahtab","family":"Forouzandeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaren","family":"Besen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"de Rivero Vaccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3171\/2012.9.JNS12815","article-title":"Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article","volume":"117","author":"Adamczak","year":"2012","journal-title":"J. Neurosurg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies","author":"Alinaghi","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12950-016-0137-0","article-title":"Acidification changes affect the inflammasome in human nucleus pulposus cells","volume":"13","author":"Brand","year":"2016","journal-title":"J. Inflammation (Lond)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/exd.12049","article-title":"Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility","volume":"21","author":"Carlstrom","year":"2012","journal-title":"Exp. Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/ijms21051668","article-title":"DROSHA-Dependent miRNA and AIM2 Inflammasome Activation in Idiopathic Pulmonary Fibrosis","volume":"21","author":"Cho","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B6","first-page":"210","article-title":"Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions","volume":"15","author":"Companjen","year":"2004","journal-title":"Eur. Cytokine Netw."},{"key":"B7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/jcbfm.2013.227","article-title":"Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury","volume":"34","author":"De Rivero Vaccari","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/eji.1830250623","article-title":"Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release","volume":"25","author":"Debets","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/bjd.13178","article-title":"Genetic variations of NLRP1: susceptibility in psoriasis","volume":"171","author":"Ekman","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1046\/j.1468-3083.2003.00647.x","article-title":"Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations","volume":"17","author":"Gangemi","year":"2003","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.molimm.2016.03.009","article-title":"Keratinocytes express functional CARD18, a negative regulator of inflammasome activation, and its altered expression in psoriasis may contribute to disease pathogenesis","volume":"73","author":"Goblos","year":"2016","journal-title":"Mol. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"B13","first-page":"1394","article-title":"[Expression of NLRP3 inflammasome in BALB\/c mice with imiquimod-induced psoriasis-like inflammation and therapeutic effect of mustard seed (Sinapis Alba Linn)]","volume":"33","author":"Hu","year":"2013","journal-title":"Nan. Fang Yi Ke Da Xue Xue Bao"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/jid.2013.57","article-title":"A Toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-induced psoriasis","volume":"133","author":"Jiang","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00135","article-title":"Inflammasome Proteins As Biomarkers of Multiple Sclerosis","volume":"9","author":"Keane","year":"2018","journal-title":"Front. Neurol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00309","article-title":"Inflammasome Proteins in Serum and Serum-Derived Extracellular Vesicles as Biomarkers of Stroke","volume":"11","author":"Kerr","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0210128","DOI":"10.1371\/journal.pone.0210128","article-title":"Inflammasome proteins as biomarkers of traumatic brain injury","volume":"13","author":"Kerr","year":"2018","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3892\/ijmm.2018.3677","article-title":"Silencing of miR155 suppresses inflammatory responses in psoriasis through inflammasome NLRP3 regulation","volume":"42","author":"Luo","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/archderm.1991.01680050115015","article-title":"The cytokine network in psoriasis","volume":"127","author":"Nickoloff","year":"1991","journal-title":"Arch. Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1590\/abd1806-4841.20153038","article-title":"Psoriasis: classical and emerging comorbidities","volume":"90","author":"Oliveira Mde","year":"2015","journal-title":"Bras. Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12974-018-1073-0","article-title":"miRNA-23a\/CXCR4 regulates neuropathic pain via directly targeting TXNIP\/NLRP3 inflammasome axis","volume":"15","author":"Pan","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2020.2.JNS193079","article-title":"Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome","author":"Perez-Barcena","year":"2020","journal-title":"J. Neurosurg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.5114\/aoms.2011.24144","article-title":"Interleukin-18 expression and the response to treatment in patients with psoriasis","volume":"7","author":"Rasmy","year":"2011","journal-title":"Arch. Med. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/jid.2010.370","article-title":"Caspase-5 expression is upregulated in lesional psoriatic skin","volume":"131","author":"Salskov-Iversen","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.3390\/ijms21134674","article-title":"The Inflammasome Adaptor Protein ASC in Mild Cognitive Impairment and Alzheimer\u2019s Disease","volume":"21","author":"Scott","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1007\/s00018-013-1425-y","article-title":"IL-18 in inflammatory and autoimmune disease","volume":"70","author":"Sedimbi","year":"2013","journal-title":"Cell Mol. Life Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.neuron.2018.08.001","article-title":"Defective Inflammatory Pathways in Never-Treated Depressed Patients Are Associated with Poor Treatment Response","volume":"99","author":"Syed","year":"2018","journal-title":"Neuron"},{"key":"B29","first-page":"95","article-title":"Analyses of polymorphisms in the inflammasome-associated NLRP3 and miRNA-146A genes in the susceptibility to and tubal pathology of Chlamydia trachomatis infection","volume":"45","author":"Wang","year":"2009","journal-title":"Drugs Today (Barc)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.04.021","article-title":"miRNA Profiling of Extracellular Vesicles Reveals Biomarkers for Psoriasis","author":"Wang","year":"2020","journal-title":"J. Invest. Dermatol"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01238\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T05:23:42Z","timestamp":1597123422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01238\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":30,"alternative-id":["10.3389\/fphar.2020.01238"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.01238","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]},"article-number":"1238"}}